Disease progression in metastatic breast cancer is a challenge that no single entity can solve alone. Breakthroughs in ...

Pivotal trial design can make or break a new therapy's commercial viability. This article explores how choosing the right ...

Anne Zimmerman, editor-in-chief of the Columbia University online journal, <a href=" target="_blank">Voices in Bioethics ...

Disagreements about budgets can delay or stall drug development. As the clinical research industry experiences unprecedented rises in costs, having the most current data available when creating and ...

Ironwood Pharmaceuticals is a smaller company than it was in 2016, when Life Science Leader wrote a feature article about its ...

In a dramatic turn of events that makes for some great storytelling, Cidara's novel drug-Fc conjugate, once locked up in a ...

Globalization presents both opportunities and challenges for the pharmaceutical industry. Companies must navigate diverse regulatory landscapes, ensuring compliance while maintaining product quality.

This presentation highlights key pharmaceutical launches anticipated in 2025, emphasizing their potential to address unmet needs across various medical fields. The document covers new developments in ...

Protein engineering is a critical step in the development of therapeutic antibodies. Almost every facet of an antibody can be modified in one way or other. This FAQ aims to simplify some of the key ...

Longer time horizons and therapeutic area expertise make philanthropy venture capital an attractive option for ...